Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series

Saved in:
Bibliographic Details
Main Authors: Agnieszka Nowosielska, Tomasz Wójtowicz, Emilija Narvydaitė
Format: Article
Language:English
Published: Termedia Publishing House 2024-03-01
Series:Klinika Oczna
Subjects:
Online Access:https://www.termedia.pl/Vitrectomy-with-subretinal-tissue-plasminogen-activator-and-intravitreal-injection-of-bevacizumab-in-the-treatment-of-submacular-haemorrhage-secondary-to-wet-AMD-case-series,124,52727,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589530332397568
author Agnieszka Nowosielska
Tomasz Wójtowicz
Emilija Narvydaitė
author_facet Agnieszka Nowosielska
Tomasz Wójtowicz
Emilija Narvydaitė
author_sort Agnieszka Nowosielska
collection DOAJ
format Article
id doaj-art-3971df5df87342ffa29411125789bb95
institution Kabale University
issn 0023-2157
2719-3209
language English
publishDate 2024-03-01
publisher Termedia Publishing House
record_format Article
series Klinika Oczna
spelling doaj-art-3971df5df87342ffa29411125789bb952025-01-24T13:00:46ZengTermedia Publishing HouseKlinika Oczna0023-21572719-32092024-03-011261394410.5114/ko.2024.13698752727Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case seriesAgnieszka NowosielskaTomasz WójtowiczEmilija Narvydaitėhttps://www.termedia.pl/Vitrectomy-with-subretinal-tissue-plasminogen-activator-and-intravitreal-injection-of-bevacizumab-in-the-treatment-of-submacular-haemorrhage-secondary-to-wet-AMD-case-series,124,52727,1,1.htmlage-related macular degeneration submacular haemorrhage tpa tissue plasminogen activator vitrectomy
spellingShingle Agnieszka Nowosielska
Tomasz Wójtowicz
Emilija Narvydaitė
Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
Klinika Oczna
age-related macular degeneration
submacular haemorrhage
tpa
tissue plasminogen activator
vitrectomy
title Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
title_full Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
title_fullStr Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
title_full_unstemmed Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
title_short Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
title_sort vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet amd case series
topic age-related macular degeneration
submacular haemorrhage
tpa
tissue plasminogen activator
vitrectomy
url https://www.termedia.pl/Vitrectomy-with-subretinal-tissue-plasminogen-activator-and-intravitreal-injection-of-bevacizumab-in-the-treatment-of-submacular-haemorrhage-secondary-to-wet-AMD-case-series,124,52727,1,1.html
work_keys_str_mv AT agnieszkanowosielska vitrectomywithsubretinaltissueplasminogenactivatorandintravitrealinjectionofbevacizumabinthetreatmentofsubmacularhaemorrhagesecondarytowetamdcaseseries
AT tomaszwojtowicz vitrectomywithsubretinaltissueplasminogenactivatorandintravitrealinjectionofbevacizumabinthetreatmentofsubmacularhaemorrhagesecondarytowetamdcaseseries
AT emilijanarvydaite vitrectomywithsubretinaltissueplasminogenactivatorandintravitrealinjectionofbevacizumabinthetreatmentofsubmacularhaemorrhagesecondarytowetamdcaseseries